Elizabeth Mormino, Ph.D. - Related publications

Affiliations: 
MGH/HMS 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
22 most relevant papers in past 60 days:
Year Citation  Score
2022 Lee LH, Yip PC, Fan YM, Liu YC. Thymoma Removal Improved Cognitive Function in a Patient with Alzheimer disease: A Case Report. Acta Neurologica Taiwanica. PMID 35040111   
2022 Frisoni GB, Altomare D, Thal DR, Ribaldi F, van der Kant R, Ossenkoppele R, Blennow K, Cummings J, van Duijn C, Nilsson PM, Dietrich PY, Scheltens P, Dubois B. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nature Reviews. Neuroscience. 23: 53-66. PMID 34815562 DOI: 10.1038/s41583-021-00533-w   
2022 Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, Suhy J, Forrestal F, Tian Y, Umans K, Wang G, Singhal P, Budd Haeberlein S, Smirnakis K. Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease. Jama Neurology. 79: 13-21. PMID 34807243 DOI: 10.1001/jamaneurol.2021.4161   
2022 Ciampa CJ, Parent JH, Harrison TM, Fain RM, Betts MJ, Maass A, Winer JR, Baker SL, Janabi M, Furman DJ, D'Esposito M, Jagust WJ, Berry AS. Associations among locus coeruleus catecholamines, tau pathology, and memory in aging. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35034099 DOI: 10.1038/s41386-022-01269-6   
2022 Moussavi Z, Kimura K, Lithgow B. Egocentric spatial orientation differences between Alzheimer's disease at early stages and mild cognitive impairment: a diagnostic aid. Medical & Biological Engineering & Computing. PMID 35013869 DOI: 10.1007/s11517-021-02478-9   
2022 Zamanian J, Khoshbin Z, Abnous K, Taghdisi SM, Hosseinzadeh H, Danesh NM. Current progress in aptamer-based sensing tools for ultra-low level monitoring of Alzheimer's disease biomarkers. Biosensors & Bioelectronics. 197: 113789. PMID 34798498 DOI: 10.1016/j.bios.2021.113789   
2022 Jiang J, Wang M, Alberts I, Sun X, Li T, Rominger A, Zuo C, Han Y, Shi K, Initiative FTADN. Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. PMID 35032179 DOI: 10.1007/s00259-022-05687-y   
2022 Bian Z, Liu X, Feng T, Yu H, Hu X, Hu X, Bian Y, Sun H, Tadokoro K, Takemoto M, Yunoki T, Nakano Y, Fukui Y, Morihara R, Abe K, et al. Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimer's Disease Mice. Journal of Alzheimer's Disease : Jad. PMID 35001892 DOI: 10.3233/JAD-215318   
2022 Vemuri P, Decarli C, Duering M. Imaging Markers of Vascular Brain Health: Quantification, Clinical Implications, and Future Directions. Stroke. 53: 416-426. PMID 35000423 DOI: 10.1161/STROKEAHA.120.032611   
2022 Wisse LE, Xie L, Das SR, de Flores R, Hansson O, Habes M, Doshi J, Davatzikos C, Yushkevich PA, Wolk DA, . Tau pathology mediates age effects on medial temporal lobe structure. Neurobiology of Aging. 109: 135-144. PMID 34740075 DOI: 10.1016/j.neurobiolaging.2021.09.017   
2022 Pavlik VN, Burnham SC, Kass JS, Helmer C, Palmqvist S, Vassilaki M, Dartigues JF, Hansson O, Masters CL, Pérès K, Petersen RC, Stomrud E, Butler L, Coloma PM, Teitsma XM, ... , et al. Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration Network. Journal of Alzheimer's Disease : Jad. 85: 31-45. PMID 34776434 DOI: 10.3233/JAD-210525   
2022 Song R, Wu X, Liu H, Guo D, Tang L, Zhang W, Feng J, Li C. Prediction of Cognitive Progression in Individuals with Mild Cognitive Impairment Using Radiomics as an Improvement of the ATN System: A Five-Year Follow-Up Study. Korean Journal of Radiology. 23: 89-100. PMID 34983097 DOI: 10.3348/kjr.2021.0323   
2022 Lee PJ, Tsai CL, Liang CS, Peng GS, Lee JT, Tsai CK, Lin YK, Yang FY. Biomarkers with Plasma Amyloid β and Tau Protein Assayed by Immunomagnetic Reduction in Patients with Amnestic Mild Cognitive Impairment and Alzheimer's Disease. Acta Neurologica Taiwanica. 31: 53-60. PMID 35040113   
2022 Wang J, Fan DY, Li HY, He CY, Shen YY, Zeng GH, Chen DW, Yi X, Ma YH, Yu JT, Wang YJ. Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers. Molecular Neurodegeneration. 17: 9. PMID 35033164 DOI: 10.1186/s13024-021-00512-w   
2022 Asih PR, Stefanoska K, Prikas E, Ittner A. High level forebrain expression of active tau kinase p38γ exacerbates cognitive dysfunction in aged APP-transgenic alzheimer's mice. Neuroscience. PMID 35031398 DOI: 10.1016/j.neuroscience.2022.01.005   
2022 Reyes-Dumeyer D, Faber K, Vardarajan B, Goate A, Renton A, Chao M, Boeve B, Cruchaga C, Pericak-Vance M, Haines JL, Rosenberg R, Tsuang D, Sweet RA, Bennett DA, Wilson RS, et al. The National Institute on Aging Late-Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34978149 DOI: 10.1002/alz.12514   
2022 Geng D, Wang Y, Gao Z, Wang J, Liu X, Pang G. Effects of Alzheimer's disease of varying severity on cardiac and autonomic function. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas. 55: e11504. PMID 35019033 DOI: 10.1590/1414-431X2021e11504   
2022 Visser D, Verfaillie SCJ, Wolters EE, Coomans EM, Timmers T, Tuncel H, Boellaard R, Golla SSV, Windhorst AD, Scheltens P, van der Flier WM, van Berckel BNM, Ossenkoppele R. Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34997294 DOI: 10.1007/s00259-021-05669-6   
2022 Bergamino M, Keeling EG, Baxter LC, Sisco NJ, Walsh RR, Stokes AM. Sex Differences in Alzheimer's Disease Revealed by Free-Water Diffusion Tensor Imaging and Voxel-Based Morphometry. Journal of Alzheimer's Disease : Jad. 85: 395-414. PMID 34842185 DOI: 10.3233/JAD-210406   
2022 Lin L, Hua F, Salinas C, Young C, Bussiere T, Apgar JF, Burke JM, Muralidharan K, Rajagovindan R, Nestorov I. Quantitative systems pharmacology model for Alzheimer's disease to predict effect of aducanumab on brain amyloid. Cpt: Pharmacometrics & Systems Pharmacology. PMID 35029320 DOI: 10.1002/psp4.12759   
2022 Bigley TM, Xiong M, Ali M, Chen Y, Wang C, Serrano JR, Eteleeb A, Harari O, Yang L, Patel SJ, Cruchaga C, Yokoyama WM, Holtzman DM. Murine roseolovirus does not accelerate amyloid-β pathology and human roseoloviruses are not over-represented in Alzheimer disease brains. Molecular Neurodegeneration. 17: 10. PMID 35033173 DOI: 10.1186/s13024-021-00514-8   
2022 Kara F, Joers JM, Deelchand DK, Park YW, Przybelski SA, Lesnick TG, Senjem ML, Zeydan B, Knopman DS, Lowe VJ, Vemuri P, Mielke MM, Machulda MM, Jack CR, Petersen RC, et al. H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults. Neurobiology of Aging. 112: 16-26. PMID 35038671 DOI: 10.1016/j.neurobiolaging.2021.12.010